Perspective Therapeutics, Inc. (NYSE:CATX) appears in 2 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 4,559,977 | 193,400 | 4.43% | $12,539,939.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 4,559,977 | 193,400 | 4.43% | $12,539,939.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 4,559,977 | 193,400 | 4.43% | $12,539,939.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 4,559,977 | 193,400 | 4.43% | $12,539,939.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 4,559,977 | 193,400 | 4.43% | $12,539,939.00 |
| Morgan Stanley | 31 Dec, 2025 | 4,474,522 | 1,713,661 | 62.07% | $12,304,936.00 |
| Morgan Stanley | 31 Dec, 2025 | 4,474,522 | 1,713,661 | 62.07% | $12,304,936.00 |
| Morgan Stanley | 31 Dec, 2025 | 4,474,522 | 1,713,661 | 62.07% | $12,304,936.00 |
| Morgan Stanley | 31 Dec, 2025 | 4,474,522 | 1,713,661 | 62.07% | $12,304,936.00 |
| Morgan Stanley | 31 Dec, 2025 | 4,474,522 | 1,713,661 | 62.07% | $12,304,936.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,490,658 | 52,793 | 1.54% | $9,599,310.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,490,658 | 52,793 | 1.54% | $9,599,310.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,490,658 | 52,793 | 1.54% | $9,599,310.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,490,658 | 52,793 | 1.54% | $9,599,310.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 3,490,658 | 52,793 | 1.54% | $9,599,310.00 |
| Avidity Partners Management LP | 31 Dec, 2025 | 3,210,733 | 216,700 | 7.24% | $8,829,516.00 |
| Avidity Partners Management LP | 31 Dec, 2025 | 3,210,733 | 216,700 | 7.24% | $8,829,516.00 |
| Avidity Partners Management LP | 31 Dec, 2025 | 3,210,733 | 216,700 | 7.24% | $8,829,516.00 |
| Avidity Partners Management LP | 31 Dec, 2025 | 3,210,733 | 216,700 | 7.24% | $8,829,516.00 |
| Avidity Partners Management LP | 31 Dec, 2025 | 3,210,733 | 216,700 | 7.24% | $8,829,516.00 |